Pharmaceutical Regulation Expert Witnesses in New Jersey

Ventnor City, New Jersey

Pharmacist, Pharmaceutical Regulation - Geriatrics, Addiction, Opioids, Hospitals, Dialysis, Behavioral Health, Drug Distributors, Drug Companies, Long Term Care, Assisted Living, Pharmacies, Professional Practice, Regulatory Compliance, Duty of Care, Duty to Warn, Product Liability, Pharmacology, Toxicology, Abuse, Overdose

Dr. Frank Breve is an independent contractor consultant pharmacist. He is President and CEO of Mid Atlantic PharmaTech Consultants, LLC, a for profit company. Dr. Breve is also President and CEO of Opioid Consulting Educational Solutions, a 501(c)(3) non-profit corporation. He is adjunct faculty at Temple University School of Pharmacy in Philadelphia, and at University of Colorado Skaggs School of Pharmacy in Denver. Dr. Breve has authored over sixty scientific publications in peer reviewed journals. Dr. Breve is past president of the New Jersey Pharmacists Association, and a member of various professional societies and committees. He has been the recipient of many awards in his field of practice. Dr. Breve has served as an expert witness for roughly twenty years, and has worked on numerous cases, representing both plaintiffs and defendants.

West New York, New Jersey

Marketing, Pharmaceutical Regulation - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Promotion, CNS Products, Medicare, Launch delay, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE, Pharmaceuticals , Promotional compliance

Mr. Hosier is a strategic advisor to the life sciences industry drawing on 30 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr. Hosier’s firm has architected the launch of rare disease and oncology business units for multiple pharmaceutical clients (large and small); led development of the managed markets, trade, and distribution strategy for the launch of new chemical entities (NCEs) and 505(b)2 assets for various organizations; advised on commercially reasonable effort (CRE); and provided commerci...